Evidence map›Paper›PMID 40134819›Full record

ArticleQatar medical journal2025

The prevalence of depression and anxiety symptoms and their associated factors among patients with cancer in Qatar: A cross-sectional study.

Majid Alabdulla, Shuja Reagu, Moza Alishaq, Noora Al Hammadi, Mohammed Hassan Elkordy, Hafedh Ghazouani, Ahmed H Assar

Abstract read
In one paragraph

Article in Qatar medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Majid Alabdulla
Shuja ReaguDepartment of Psychiatry, Hamad Medical Corporation, Doha, Qatar.
Moza AlishaqCorporate Quality Improvement and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
Noora Al HammadiNational Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar*Correspondence: Mohammed Hassan Elkordy. Email: mali51@hamad.qa.
Mohammed Hassan ElkordyCorporate Quality Improvement and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
Hafedh GhazouaniCorporate Quality Improvement and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
Ahmed H AssarDepartment of Psychiatry, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer is a significant global health challenge. One of the biggest health issues that cancer patients face is depression and anxiety. This has a significant impact on their quality of life and treatment outcomes. Aim: The aim of this study was to investigate the frequency of depression and anxiety among cancer patients in Qatar. Materials and methods: This study was a cross-sectional design using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. A total of 500 cancer patients were surveyed from the National Center for Cancer Care and Research in Doha. Results: The study found that a significant proportion of cancer patients suffered from depression, with an average PHQ-9 score indicating mild levels of severity. Depression was commonly categorized as mild, with a smaller percentage experiencing moderate, moderate-to-severe, or severe depression. Additionally, patients were predominantly anxious, as reflected by an average GAD-7 score, with most patients experiencing mild to moderate symptoms, while a few experienced moderate or severe anxiety. These findings highlight the significant prevalence of both depression and anxiety among cancer patients, pointing to the importance of comprehensive mental health support. Moreover, patients with advanced-stage cancer, those in their 40s and 60s, those undergoing radiotherapy or hormone therapy, and female patients were found to be more susceptible to depression and anxiety. Conclusion: Treatment of mental health issues is essential to enhancing the effectiveness of cancer treatment. Cancer patients can have a higher quality of life and better adherence to cancer treatments when mental illnesses such as depression and anxiety are identified and treated early. Furthermore, most patients reported having depression and anxiety, according to the study, which showed that these conditions were more common in Qatar than in other countries. Several demographic groups have been linked to higher rates of depression and anxiety, including women, middle-aged adults, people with stage IV cancer, and patients receiving therapies such as radiotherapy and chemotherapy.

Indexed as

AnxietycancerdepressionpatientsQatarsociodemographic factors

Identifiers

PMID40134819
PMCPMC11934930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.